Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population

European Journal of Gynaecological Oncology

Volumn 30, Issue 4, 2009, Pages 412-414

  Yilmaz, N ^a,b   Sahin, I ^a   Kilic, S ^a   Ozgu, E ^a   Gungor, T ^a   Bilge, U ^a  

^a Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

CA125; Uterine leiomyoma; Uterine sarcoma

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CARCINOSARCOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; TURKEY (REPUBLIC); UTERUS MYOMA; UTERUS SARCOMA;

ADULT; AGED; CA-125 ANTIGEN; CARCINOSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEIOMYOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SARCOMA; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 68849098222     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schwartz P.E., Kelly M.G.: "Malign transformation of myomas: myth or reality?". Obstet. Gynecol. Clin. No. Am., 2006, 33, 183.
2. Buttram V.C. Jr., Reiter R.C.: "Uterine leiomyomata: etiology, symptomatology and management". Fertil. Steril., 1981, 36, 433.
3. Christopherson W., Wiliamson E., Gray L.: "Leiomyosarcoma of uterus". Cancer, 1972, 29, 1512.
4. Haberal A., Kayikçioglu F., Yiǧitbaşi S.: "Leiomyoma ön tanisi ile yapilan operasyonlarda post operatif Uterine sarcoma sikliǧi". Turkiye Klinikleri Jinekoloji Obstetik, 2004, 6, 299.
5. Liepshon S., D'Ablaing G., Mishell D.R.: "Leoimyosarcoma in series of hysterectomies performed for presumed leiomyomas". Am. J. Obstet. Gynecol., 1990, 162, 968 (Pubitemid 20155415)
6. Brooks S.E., Zhan M., Cote T., Baquet C.R.: "Surveillance, epidemiology and end results analysis of 2,677 cases of uterine sarcoma 1989-1999". Gynecol. Oncol., 2004, 93, 204.
7. Schwartz S.M., Weiss N.S., Daling J.R., Gammon M.D., Liff J.M., Watt J. et al.: "Exogenous sex hormone use, correlates of endogen hormone levels and incidence of histologic types of sarcoma of the uterus". Cancer, 1996, 77, 717. (Pubitemid 26055397)
8. Wyoswski D.: "Uterine sarcoma associated with tamoxifen use". N. Eng. J. Med., 2002, 20, 2758.
9. Parker W.H., Fu Y.S., Berek J.S.: "Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma". Obstet. Gynecol., 1994, 82, 414.
10. O'Brien T.J., Tanimato H., Konishi I., Gee M.: "More than 15 years of Ca 125; what is known about the antigen, its structure and its function". Int. J. Biol. Markers, 1998, 13, 188. (Pubitemid 29178547)
11. Kato H., Hatori M., Kokubun S., Watanabe M., Smith A.R., Hotta T., Ogose A., Morita T.: Jpn. J. Clin. Oncol., 2004, 34, 149.
12. Holcomb K., Francis M., Ruiz J., Abulafia O., Matthews R.P., Lee Y.C.: "Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA 125". Gynecol. Oncol., 1999, 74, 499. (Pubitemid 29439899)
13. Juang C.M., Yen M.S., Horng H.C., Twu N.F., Yu H.C., Hsu W.L.: "Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma". Eur. J. Gynaecol. Oncol., 2006, 27, 370.
14. Zotter S., Hagema P.C., Lossnitzer A., Mooi W.J., Hilgers J.: "Tissue and tumor distribution of human polymorphic epithelial mucin" (review). Cancer, 1988, 11, 55.
15. Fizazi K., Farhat F., Theodore C., Rixe O.: "CA 125 and neuronspecific enorase (NSE) as tumor markers for intraabdominal desmoblastic small round cell tumors". Br. J. Cancer, 1997, 75, 76.
16. Whiteley M.S., Marshall J.: "Raised serum CA 125 level in leiomyoma and leiomyosarcoma of gastrointestinal origin". Br. J Surg., 1993, 80, 1551.
17. Hoskins P.J., Le N.: "Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus". Int. J. Gynecol. Cancer, 2008, 18, 1200.